BNP Paribas Financial Markets’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-36,295
| Closed | -$5.49M | – | 4285 |
|
|
2022
Q3 | $5.49M | Buy |
36,295
+22,411
| +161% | +$3.39M | 0.01% | 935 |
|
|
2022
Q2 | $2.02M | Buy |
13,884
+8,242
| +146% | +$1.2M | ﹤0.01% | 1271 |
|
|
2022
Q1 | $669K | Sell |
5,642
-7,851
| -58% | -$931K | ﹤0.01% | 2054 |
|
|
2021
Q4 | $1.86M | Buy |
13,493
+2,281
| +20% | +$314K | ﹤0.01% | 1587 |
|
|
2021
Q3 | $1.56M | Buy |
11,212
+9,223
| +464% | +$1.28M | ﹤0.01% | 1592 |
|
|
2021
Q2 | $193K | Sell |
1,989
-4,145
| -68% | -$402K | ﹤0.01% | 2294 |
|
|
2021
Q1 | $419K | Sell |
6,134
-1,146
| -16% | -$78.3K | ﹤0.01% | 2128 |
|
|
2020
Q4 | $624K | Sell |
7,280
-4,004
| -35% | -$343K | ﹤0.01% | 1746 |
|
|
2020
Q3 | $734K | Buy |
11,284
+7,183
| +175% | +$467K | ﹤0.01% | 1438 |
|
|
2020
Q2 | $300K | Sell |
4,101
-39,620
| -91% | -$2.9M | ﹤0.01% | 1729 |
|
|
2020
Q1 | $1.49M | Buy |
43,721
+38,810
| +790% | +$1.32M | ﹤0.01% | 1212 |
|
|
2019
Q4 | $267K | Sell |
4,911
-858
| -15% | -$46.7K | ﹤0.01% | 2188 |
|
|
2019
Q3 | $241K | Buy |
5,769
+2,294
| +66% | +$95.7K | ﹤0.01% | 2052 |
|
|
2019
Q2 | $152K | Sell |
3,475
-3,025
| -47% | -$132K | ﹤0.01% | 2183 |
|
|
2019
Q1 | $335K | Buy |
+6,500
| New | +$335K | ﹤0.01% | 1814 |
|
|
2018
Q4 | – | Sell |
-873
| Closed | -$32.8K | – | 3829 |
|
|
2018
Q3 | $32.8K | Hold |
873
| – | – | ﹤0.01% | 2551 |
|
|
2018
Q2 | $34.5K | Sell |
873
-5,426
| -86% | -$214K | ﹤0.01% | 2627 |
|
|
2018
Q1 | $162K | Buy |
6,299
+4,121
| +189% | +$106K | ﹤0.01% | 2355 |
|
|
2017
Q4 | $58.8K | Buy |
2,178
+732
| +51% | +$19.7K | ﹤0.01% | 2916 |
|
|
2017
Q3 | $54.1K | Buy |
1,446
+398
| +38% | +$14.9K | ﹤0.01% | 2658 |
|
|
2017
Q2 | $26.2K | Buy |
+1,048
| New | +$26.2K | ﹤0.01% | 2997 |
|